Chagas disease reactivation in rheumatologic patients: association with immunosuppressive therapy and humoral response
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Rheumatology"
DOI: 10.1007/s10067-021-05581-2
Abstract: Evidence for Chagas disease reactivation (CDR) in rheumatologic patients under rheumatologic treatments (RTs) is scarce. To screen and follow-up patients with rheumatic diseases and concomitant Chagas disease under RT to detect CDR and to describe… read more here.
Keywords: cdr; disease reactivation; chagas disease; disease ... See more keywords
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000201029
Abstract: Background and Objectives To evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy. Methods This was a retrospective cohort study from 2 large observational MS registries: MSBase and… read more here.
Keywords: disease; disease reactivation; therapy; cessation ... See more keywords
Chagas disease reactivation: cutaneous manifestations in a transplanted patient.
Sign Up to like & getrecommendations! Published in 2018 at "Anais brasileiros de dermatologia"
DOI: 10.1590/abd1806-4841.20187855
Abstract: Chagas disease is an endemic zoonosis caused by a protozoan agent called Trypanosoma cruzi. It is mainly transmitted by a hematophagous vector, and less frequently by blood transfusion, transplacental and solid organ transplant. In most… read more here.
Keywords: reactivation cutaneous; disease reactivation; disease; reactivation ... See more keywords